• Title/Summary/Keyword: 순응도

Search Result 759, Processing Time 0.032 seconds

Analysis of the medication compliance of hypertensives and its influential factors (고혈압 환자의 투약순응도와 영향 요인 분석)

  • Jeong, Mi-Ae
    • Proceedings of the KAIS Fall Conference
    • /
    • 2010.05b
    • /
    • pp.588-591
    • /
    • 2010
  • 본 연구는 행정자료인 건강보험 및 의료급여비용 청구자료를 이용하여 고혈압 환자의 투약 순응도를 분석하였으며, 투약순응도에 영향을 미치는 요인에 대하여 조사한 결과 아래와 같다. 연구대상자의 투약일수를 살펴보면 6개월 동안 148일(80%) 이상 혈압강하제를 처방받은 환자는 13.0%에 불과하였다. 고혈압상병(주.부상병)으로 외래를 방문한 평균 횟수는 4.3일, 방문한 기관수는 평균 1.1곳이었고, 한곳의 의료기관만을 이용한 환자가 전체의 94.9%로 나타났다. 당뇨병을 동반상병으로 가지고 있는 환자가 11.6%로 가장 많았고 고혈압 환자의 23.3%가 동반상병을 가지고 있었다. 연구 대상자 특성별 투약순응도를 비교해 보면, 남성, 건강보험 가입자, 종합전문을 주이용기관으로 이용하는 환자, 동반상병을 가지고 있는 환자에서 투약 순응도가 높았다. 65-74세까지 투약 순응도가 증가하다가 그 후 감소하는 경향을 보였다. 고혈압 환자의 투약 순응도에 영향을 미치는 요인 조사 결과 남성, 55-64세, 건강보험 가입자가 투약순응도가 높게 나타났다. 외래방문횟수가 증가할수록 투약 순응도가 증가하였다. 종합전문, 종합병원, 보건기관을 주 이용기관으로 방문하는 환자와 심장질환, 당뇨병을 동반상병으로 가지고 있는 환자에서 투약순응도가 높았다.

  • PDF

A Study on ON/OFF Time of Aroma Emission System (자동차용 향 발생 장치의 향 분사 주기 연구)

  • 김익현;정안나;설정현;정순철;김승철
    • Proceedings of the Korean Society for Emotion and Sensibility Conference
    • /
    • 2002.11a
    • /
    • pp.229-232
    • /
    • 2002
  • 본 연구에서는 운전자의 피로감을 경감시킬 수 있도록 개발된 자동차용 향 발생장치의 향분사주기에 대해 연구하였다. 평균나이 22+2세인 남녀 대학생 20명을 대상으로 4가지 천연향(쟈스민 30%, 쟈스민 50%, 페파민트 30%, 페파민트 50%)을 사용하여 향에 순응화가 발생하는 시간과 향에 대한 순응화가 제거되는 시간 및 호감도 실험을 수행하였다. 실험 결과 쟈스민 30%의 순응화가 발생되는 시간은 1분 28초, 순응화가 제거되는 시간은 3분 15초, 쟈스민 50%에서 순응화가 발생하는 시간은 2분 41초, 순응화가 제거 되는 시간은 4분 3초, 페파민트 30%에서 순응화가 발생하는 시간은 1분 47초, 순응화가 제거되는 시간은 2분 59초, 페파민트 50%에서 순응화가 발생하는 시간은 1분 58초, 순응화가 제거되는 시간은 4분11초였다. 호감도 결과는 쟈스민 30%의 호감도가 0.94로 나와 가장 선호하는 향인 것으로 밝혀졌다.

  • PDF

Predictors of Persistence and Adherence with Secondary Preventive Medication in Stroke Patients (지역사회 뇌졸중 환자들의 이차 예방을 위한 치료 지속률과 약물 순응도 관련 요인)

  • Kim, Young Taek;Park, Ki Soo;Bae, Sang-Geun
    • Journal of agricultural medicine and community health
    • /
    • v.40 no.1
    • /
    • pp.9-20
    • /
    • 2015
  • Objectives: This study aimed to explore the persistence and adherence to secondary preventive medication of stroke patients after discharge and to assess the reasons for persistence and nonadherence. Methods: Four hundred twenty-nine patients with stroke were surveyed to determine their behaviors from discharge. Reasons for stopping medications were ascertained. Persistence was defined as continuation of all secondary preventive medications prescribed at hospital discharge, and adherence as continuation of prescribed medications according to health care provider instructions. Results: Of the 429 patients, 86.5% were treatment persistent and 41.2%(non-intentional nonadherence=39.4%, intentional nonadherence=19.4%) were adherent. Independent predictors of persistence included having experience about health education. Independent predictors of non-intentional nonadherence were modified Rankin Scale(mRS) (Exp(B)=2.858, p=0.001) and health education experience (Exp(B)=0.472, p=0.032), and independent predictors of intentional nonadherence were mRS (Exp(B)=2.533, p=0.006), depressive symptoms (Exp(B)=1.113, p=0.016), beliefs about medications questionnaire(necessity, Exp(B)=0.879, p=0.011, concern, Exp(B)=1.098, p=0.019). Conclusions: Although up to one-ninth of stroke patients continued secondary prevention medications, nonadherence is common. Several potentially modifiable patient, provider, and system-level factors associated with persistence and adherence may be targets for future interventions. Specially, interventions to improve adherence should target patients' beliefs about their medication.

COMPLIANCE STUDY OF METHYLPHENIDATE IR IN THE TREATMENT OF ADHD (주의력결핍과잉행동장애 치료 약물 Methylphenidate IR의 순응도 연구)

  • Hwang, Jun-Wan;Cho, Soo-Churl;Kim, Boong-Nyun
    • Journal of the Korean Academy of Child and Adolescent Psychiatry
    • /
    • v.15 no.2
    • /
    • pp.160-167
    • /
    • 2004
  • Objectives : There have been very few studies on the compliance of methylphenidate-immediate releasing form(MPH-IR), which is the most frequently used drug in Korea, in Attention Deficit Hyperactivity Disorder(ADHD). This study was conducted to investigate the compliance rate and the related factors in the one year pharmacotherapy process via OPD for children with ADHD. Method : Total 100 ADHD patients were selected randomly among patients who have been treated with MPH-IR from September in 2002 to December in 2002. All the selected patients were diagnosed with DSM-IV-ADHD criteria and fulfilled the inclusion criteria. In March, 2003(at the time of 6 month treatment), all the patients and parents received the questionnaire for the compliance and satisfaction for MPH-IR treatment. In October 2003(at time of 1 year treatment), we, investigators evaluated the socio-demographic variables, developmental data, medical data, family data, comorbid disorders, treatment variables, and compliance rate. Through these very comprehensive data, The compliance rate at the time of mean 1 year treatment and the related factors were investigated. Result : 1) In the questionnaire for compliance and satisfaction for MPND treatment, the 60% of respondents(parents) reported more than moderate degree of satisfaction in the effectiveness of MPND. Their compliance rate for the morning prescription was 81%, but the rate of afternoon prescription was 43%. 2) In the evaluation at the time of 1 year treatment(October 2003), the 38% of parents were dropped out from the OPD treatment. The mean compliance rate for the 1 year treatment was 62%. the 38% of parents were dropped out from the OPD treatment. The mean compliance rate for the 1year treatment was 62%. 3) Compared with the noncompliant group(drop-out group), compliant group showed higher total, verbal and performance IQ scores. In the treatment variables, higher reposponder rate(clinician rating), higher medication dosage and more compliance rate in afternoon prescription were found in the compliant group compared with the noncompliant group. There were no statistical differences in the demographic variables(age, sex, SES, parental education level), medical data, developmental profiles and academic function. Conclusion : To our knowledge, this is the first report about the compliance rate of the MPH-IR treatment for the children with ADHD. The compliance rate at the time of mean 1year treatment was 62%, which was comparable with other studies performed in foreign countries, especially States. In this study, the compliance related factors were IQ score, clinical treatment response, dosage of MPH-IR, and early compliance for the afternoon prescription. These results suggest that clinician plan the strategies for the promotion of the early compliance for the after prescription and enhancement of overall treatment response.

  • PDF

환자는 무엇을 해야 하는지 알아야 한다

  • 류우진
    • 보건세계
    • /
    • v.40 no.9 s.445
    • /
    • pp.4-7
    • /
    • 1993
  • 결핵은 적절한 처방에 따른 약제를 일정기간동안 규칙적으로 복용하면 완치되는 질환이다. 약을 제대로 복용하지 않을 경우에는 치료실패와 재발이 되며 약제 내성균의 전파, 경제적 손실 그리고 사망까지 초래한다. 따라서 결핵환자의 순응도는 치료처방에 따라 약을 규칙적으로 주워진 기간동안 복용하는 환자의 행동을 의미하며 이것이 결핵치료의 성공여부를 결정짓는 가장 중요한 요인이다. 그래서 결핵치료에 있어서 보다 관심을 기울여야 할 사항은 결핵약제보다는 환자의 순응도를 높이는 데 있다. 이번 달에는 환자에게 교육을 시키므로 내원 약속일을 지키게 하는 등 환자의 순응도를 높이기 위한 방안들을 서술한다

  • PDF

Analysis of the Medication Adherence of Hypertensives and Influential Factors (고혈압 환자의 투약순응도와 이에 영향을 미치는 요인 분석)

  • Jeong, Mi-Ae
    • Proceedings of the Korea Contents Association Conference
    • /
    • 2010.05a
    • /
    • pp.207-209
    • /
    • 2010
  • 본 연구는 행정자료인 건강보험 및 의료급여비용 청구자료를 이용하였으며, 일개지역(2개도, 남북)에 개설되어있는 전체 의료기관을 대상으로 진료일 기준 '08.7월~'08.12월(184일)동안 외래 방문이 1회 이상인 30세 이상의 수진자 432,915명을 대상으로 하였다. 투약순응도와 영향 요인을 분석하였다. 투약순응도에 영향을 미치는 요인으로는 남성, 55~64세, 건강보험 가입자가, 종합전문, 종합병원, 보건기관을 주 이용기관으로 방문하는 환자와 심장질환, 당뇨병을 동반상병으로 가지고 있는 환자에서 투약순응도가 높았다. 본 연구 결과 투약 순응도가 낮은 환자에 대한 다양한 요인분석이 필요하며, 투약 순응도를 높이기 위한 고혈압관리사업의 정책적 검토 및 대안이 필요할 것이다.

  • PDF

The Compliance and Effect of CPAP in Obstructive Sleep Apnea Syndrome (폐쇄성 수면 무호흡 환자에서 지속적 상기도 양압술의 순응도와 효과)

  • Han, Eun-Kyoung;Yoon, In-Young;Chung, Seock-Hoon
    • Sleep Medicine and Psychophysiology
    • /
    • v.13 no.2
    • /
    • pp.52-58
    • /
    • 2006
  • Objectives: Continuous positive airway pressure (CPAP) is effective in the treatment of obstructive sleep apnea syndrome (OSAS), but the major limitation of CPAP may be poor compliance. The aims of the study were to investigate the compliance and side effects of CPAP, and to evaluate the efficacy of CPAP in patients with OSAS. Methods: This study enrolled 106 patients with OSAS who took the CPAP treatment. The severity of daytime sleepiness was measured using Epworth Sleepiness Scale (ESS), and sleep quality and depressive symptoms were assessed by Pittsburgh Sleep Quality Index (PSQI) and Beck Depression Inventory (BDI), respectively. Results: During 29 months of the study period, 41.5% of patients were using CPAP and 38.7% of patients stopped using it. Compared to non-compliant patients, compliant patients had a higher PSQI score and obstructive apnea index. Among non-compliant patients, 51.2% of them stopped using CPAP within 1months. 85.7% of non-compliant patients were discomforted by the CPAP, but much more nasopharyngeal symptoms were reported in the compliant group. ESS (p<0.01), PSQI (p<0.01) and BMI (p<0.01) were reduced significantly after CPAP treatment but not BDI (p=0.86). Conclusions: We concluded that CPAP can reduce the daytime sleepiness, nocturnal sleep disturbance, and body mass index. To increase the compliance of CPAP, we suggest that some education and support are needed at the early stage of the CPAP treatment.

  • PDF

5자유도 순응기구

  • 정경한;최용제
    • Proceedings of the Korean Society of Precision Engineering Conference
    • /
    • 2003.10a
    • /
    • pp.90-90
    • /
    • 2003
  • PDF

Meta-Analysis on Effectiveness of Intervention to Improve Patient Compliance in Korean (한국인 치료순응도 향상을 위한 개입 효과에 대한 메타분석)

  • 김춘배;조희숙;현숙정;박애화
    • Health Policy and Management
    • /
    • v.12 no.2
    • /
    • pp.23-42
    • /
    • 2002
  • The purpose of this study was to analyze the results of 133 studies related to patient compliance published between 1980 and 2001 and to assess the effectiveness of intervention on compliance by using meta-analysis. We collected the existing literatures by using web and manual search 'patient compliance', 'sick role behavior', 'major clinical disease', and 'intervention' as key words and by reviewing content of journals related to medicine, nursing and public health. The compliance interventions were classified by theoretical focus into educational, behavioral, and affective categories within which specific intervention strategies were further distinguished. The compliance indicators broadly represent five classes of compliance-related assessments: (1) health outcomes (eg, blood pressure and hospitalization), (2) direct indicators (eg, urine and blood tracers and weight change), (3) indirect indicators (eg, pill count and refill records), (4) subjective report (eg, patients' or others' reports), (5) utilization (appointment making and keeping, use of preventive services). Quantitative meta-analysis was performed by MetaKorea program which was developed for meta-analysis in Korea. Among the 133 articles, 10 studies were selected through the qualitative meta-analysis process, and then only 6 studies were selected for the quantitative meta-analysis finally. The interventions produced significant effects for all the compliance indicators with the magnitude of common effect size (4.1192) than the non-intervention group in a random effect model. The largest effects were each study for patient of hypertension using health outcome such as blood pressure (0.4679) and diabetes mellitus using direct indicator such as glucose level in blood and urine (0.7753). These results suggest that strategic interventions showed clear advantage for improvement of patient compliance compared with non-intervention group.

Factors Influencing the Therapeutic Compliance of Patients with Lung Cancer (폐암환자의 치료순응도에 영향을 미치는 요인)

  • Chae, Sang-Chul;Park, Jae-Yong;Kim, Jeong-Suk;Bae, Moon-Seob;Shin, Moo-Chul;Kim, Keon-Yeob;Kim, Chang-Ho;Shon, Sang-Kyun;Kam, Sin;Jung, Tae-Hoon
    • Tuberculosis and Respiratory Diseases
    • /
    • v.45 no.5
    • /
    • pp.953-961
    • /
    • 1998
  • Background : In recent years, lung cancer has been one of most common cause of death in Korea. Despite many physician's high degree of pessimism about the gains made in treatment, progressive improvement in the survival of lung cancer by treatment has occurred, particulary in the early stages of the disease. However, a lot of patients refuse treatment or give up in the fight against the disease. This study was done to evaluate factors influencing the compliance to therapy and to lead in the establishment of special programs to enhance compliance in patients with lung cancer. Methods: The medical records of 903 patients, whose ECOG(Eastern Cooperative Oncology Group) performance status was 3 or less and whose medical record was relatively satisfactory, among 1141 patients diagnosed with lung cancer between January 1989 and December 1996 were reviewed retrospectively. Compliance was classified into three groups based on the degree of compliance with physicians practice guideline: (a) compliants; (b) patients who initially complied but gave up of themselves midway during the course of treatment; (c) noncompliants who refused the treatment. Results: The overall compliance rate was 63.9%, which was progressively increased from 57.3-61.3% in 1989 and 1990 to 64.2-67.5% in 1995 and 1996. Age, education level and occupation of patients bore statistically significant relationship with the compliance but sex, marital status and smoking history did not. The compliance was significantly higher in patients without symptoms than with, and was also significantly higher in patients with good performance status. The compliance was significantly high in patients with NSCLC(non-small cell lung cancer) compared to SCLC(small cell lung cancer), but after exclusion of stage I and II, among NSCLC, which had higher compliance to surgery there was no significant difference of compliance by histology. The compliance was significantly lower in advanced stage. Conclusion: To enhance the compliance, special care including education programs about therapy including complication and prognosis are necessary, especially for educationally and economically disadvantaged patients.

  • PDF